Bevilacqua, Arturo, and Mariano Bizzarri. “Inositols in Insulin Signaling and Glucose Metabolism.” International Journal of Endocrinology, 2018, Article ID 1968450.
Bizzarri, Mariano, et al. “Myo‑Inositol and D‑Chiro‑Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review.” Nutrients, vol. 15, no. 8, 2023, article 1875.
Nordio, Maurizio, et al. “The 40:1 Myo‑Inositol/D‑Chiro‑Inositol Plasma Ratio Is Able to Restore Ovulation in PCOS Patients: Comparison with Other Ratios.” European Review for Medical and Pharmacological Sciences, vol. 23, no. 12, 2019, pp. 5512‑5521.
Montanino Oliva, Mario, et al. “Effects of *Myo‑*Inositol plus α‑Lactalbumin in *Myo‑*Inositol‑Resistant PCOS Women.” Journal of Ovarian Research, vol. 11, 2018, article 38.
Hernández Marín, I., et al. “A Multicenter Clinical Study with *Myo‑*Inositol and Alpha‑Lactalbumin in Mexican and Italian PCOS Patients.” European Review for Medical and Pharmacological Sciences, vol. 25, no. 8, 2021, pp. 3316‑3324.
Kamenov, Zdravko, et al. “Comparing the Efficacy of Myo‑Inositol Plus α‑Lactalbumin vs. Myo‑Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome.” Metabolites, vol. 13, no. 6, 2023, article 717.
Pustotina, Olga, et al. “The Effects of Myo‑Inositol and D‑Chiro‑Inositol in a Ratio 40:1 on Hormonal and Metabolic Profile in Women with Polycystic Ovary Syndrome.” Gynecological Obstetric Investigation, vol. 89, no. 2, 2024, pp. 131‑139.